Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Long-Term Investments (2018 - 2024)

Historic Long-Term Investments for Zai Lab (ZLAB) over the last 7 years, with Q4 2024 value amounting to $3.1 million.

  • Zai Lab's Long-Term Investments fell 6621.48% to $3.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.1 million, marking a year-over-year decrease of 6621.48%. This contributed to the annual value of $3.1 million for FY2024, which is 6621.48% down from last year.
  • According to the latest figures from Q4 2024, Zai Lab's Long-Term Investments is $3.1 million, which was down 6621.48% from $3.2 million recorded in Q3 2024.
  • In the past 5 years, Zai Lab's Long-Term Investments registered a high of $20.8 million during Q3 2021, and its lowest value of $1.1 million during Q2 2021.
  • In the last 5 years, Zai Lab's Long-Term Investments had a median value of $4.3 million in 2023 and averaged $6.3 million.
  • In the last 5 years, Zai Lab's Long-Term Investments soared by 112009.38% in 2021 and then tumbled by 8405.85% in 2022.
  • Zai Lab's Long-Term Investments (Quarter) stood at $1.3 million in 2020, then surged by 1120.09% to $15.6 million in 2021, then tumbled by 58.79% to $6.4 million in 2022, then soared by 43.37% to $9.2 million in 2023, then tumbled by 66.21% to $3.1 million in 2024.
  • Its Long-Term Investments stands at $3.1 million for Q4 2024, versus $3.2 million for Q3 2024 and $4.1 million for Q2 2024.